Education
About Us
Working with TipRanks
Follow Us
Core Laboratories N.V. (CLB)
NYSE:CLB
CLB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.72 - $21.83
Previous CloseN/A
Volume23.26K
Average Volume (3M)480.49K
Market Cap
$520.05M
Enterprise Value$699.01M
Total Cash (Recent Filing)$31.19M
Total Debt (Recent Filing)$42.42M
Price to Earnings (P/E)17.6
Beta0.89
Next Earnings
Oct 22, 2025EPS Estimate
0.2Last Dividend Ex-Date
Aug 04, 2025Dividend Yield0.36%
Share Statistics
EPS (TTM)0.19
Shares Outstanding46,893,840
10 Day Avg. Volume429,486
30 Day Avg. Volume480,489
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.34
Enterprise Value/Revenue1.35
Enterprise Value/Gross Profit8.08
Enterprise Value/Ebitda9.70
Forecast
1Y Price Target
$12.00Price Target Upside8.21% Upside
Rating ConsensusHold
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe target price for the stock has been raised to $16, indicating improved cash dynamics over time.
Geopolitical FactorsPotential easing of geopolitical tensions between Russia and Ukraine could serve as a positive catalyst for the company.
Research And DevelopmentThe Research and Development division is expected to grow, likely outpacing international upstream capital expenditure growth.
Bears Say
Operational ChallengesProduction Enhancement has shrunk to just 11% of total company operating income, indicating challenges in that segment.
Core Laboratories News
CLB FAQ
What was Core Laboratories N.V.’s price range in the past 12 months?
Core Laboratories N.V. lowest stock price was $9.72 and its highest was $21.83 in the past 12 months.
What is Core Laboratories N.V.’s market cap?
Core Laboratories N.V.’s market cap is $520.05M.
When is Core Laboratories N.V.’s upcoming earnings report date?
Core Laboratories N.V.’s upcoming earnings report date is Oct 22, 2025 which is in 55 days.
How were Core Laboratories N.V.’s earnings last quarter?
Core Laboratories N.V. released its earnings results on Jul 23, 2025. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.186 by $0.004.
Is Core Laboratories N.V. overvalued?
According to Wall Street analysts Core Laboratories N.V.’s price is currently Undervalued.
Does Core Laboratories N.V. pay dividends?
Core Laboratories N.V. pays a Quarterly dividend of $0.01 which represents an annual dividend yield of 0.36%. See more information on Core Laboratories N.V. dividends here
What is Core Laboratories N.V.’s EPS estimate?
Core Laboratories N.V.’s EPS estimate is 0.2.
How many shares outstanding does Core Laboratories N.V. have?
Core Laboratories N.V. has 46,893,840 shares outstanding.
What happened to Core Laboratories N.V.’s price movement after its last earnings report?
Core Laboratories N.V. reported an EPS of $0.19 in its last earnings report, beating expectations of $0.186. Following the earnings report the stock price went up 5.868%.
Which hedge fund is a major shareholder of Core Laboratories N.V.?
Currently, no hedge funds are holding shares in CLB
Core Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.00 (8.21% Upside)
$12.00 (8.21% Upside)
Blogger Sentiment
Bullish
CLB Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-39.45%
12-Months-Change
Fundamentals
Return on Equity
11.82%
Trailing 12-Months
Asset Growth
0.72%
Trailing 12-Months
Company Description
Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
CLB Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements such as revenue growth, improved operating margins, and strategic technological advancements. However, these positives were tempered by flat year-over-year revenue, decreased net income, and ongoing geopolitical uncertainties affecting the market, leading to a balanced viewpoint on the company’s performance.View all CLB earnings summariesCLB Stock 12 Month Forecast
Average Price Target
$12.00
▲(8.21% Upside)
Technical Analysis
MRC Global
―
Oil States International
―
Tetra Technologies
―
Propetro Holding
―
National Energy Services Reunited
―
Ownership Overview
1.21% Insiders
36.89% Mutual Funds
0.07% Other Institutional Investors
34.28% Public Companies and
Individual Investors